[go: up one dir, main page]

IL162816A0 - Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera - Google Patents

Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera

Info

Publication number
IL162816A0
IL162816A0 IL16281603A IL16281603A IL162816A0 IL 162816 A0 IL162816 A0 IL 162816A0 IL 16281603 A IL16281603 A IL 16281603A IL 16281603 A IL16281603 A IL 16281603A IL 162816 A0 IL162816 A0 IL 162816A0
Authority
IL
Israel
Prior art keywords
acylaminoalkenylene
viscera
amide derivatives
motility disorders
functional motility
Prior art date
Application number
IL16281603A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL162816A0 publication Critical patent/IL162816A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
IL16281603A 2002-02-08 2003-02-07 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera IL162816A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0203061.7A GB0203061D0 (en) 2002-02-08 2002-02-08 Organic compounds
PCT/EP2003/001227 WO2003066062A1 (en) 2002-02-08 2003-02-07 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera

Publications (1)

Publication Number Publication Date
IL162816A0 true IL162816A0 (en) 2005-11-20

Family

ID=9930743

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16281603A IL162816A0 (en) 2002-02-08 2003-02-07 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera
IL162816A IL162816A (en) 2002-02-08 2004-07-01 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL162816A IL162816A (en) 2002-02-08 2004-07-01 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera

Country Status (18)

Country Link
US (2) US20050203164A1 (zh)
EP (2) EP1476167A1 (zh)
JP (2) JP2005516994A (zh)
KR (2) KR20100100994A (zh)
CN (1) CN1301714C (zh)
AU (1) AU2003244446B2 (zh)
BR (1) BR0307479A (zh)
CA (1) CA2471964A1 (zh)
GB (1) GB0203061D0 (zh)
IL (2) IL162816A0 (zh)
MX (1) MXPA04007640A (zh)
NO (1) NO20043735L (zh)
NZ (1) NZ534231A (zh)
PL (1) PL370255A1 (zh)
RU (1) RU2353356C2 (zh)
TW (1) TWI330177B (zh)
WO (1) WO2003066062A1 (zh)
ZA (1) ZA200404960B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds
MXPA06004688A (es) 2003-10-27 2006-07-05 Novartis Ag Uso de antagonistas de neuroquinina en el tratamiento de incontinencia urinaria.
US20080234345A1 (en) 2006-09-08 2008-09-25 Gene Logic Inc. Method for reducing or alleviating inflammation in the digestive tract

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217996A (en) * 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
JP3506714B2 (ja) * 1995-02-22 2004-03-15 ノバルティス・アクチエンゲゼルシャフト １−アリール−２−アシルアミノ−エタン化合物およびニューロキニン特にニューロキニン１アンタゴニストとしてのそれらの用途
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
GB9525296D0 (en) * 1995-12-11 1996-02-07 Merck Sharp & Dohme Therapeutic agents
MY132550A (en) * 1996-08-22 2007-10-31 Novartis Ag Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists
GB9708484D0 (en) * 1997-04-25 1997-06-18 Merck Sharp & Dohme Therapeutic agents
SK285644B6 (sk) * 1997-07-02 2007-05-03 Merck & Co., Inc. Polymorfná forma zlúčeniny 2-(R)-(1-(R)-(3,5-bis(trifluórmetyl)- fenyl)etoxy)-3-(S)-(4-fluór)fenyl-4-(3-(5-oxo-1H,4H-1,2,4- triazolo)metyl)morfolínu,spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie
TW520370B (en) * 1998-11-20 2003-02-11 Meiji Seika Kaisha Benzooxazole derivatives and a pharmaceutical composition containing the derivatives as an active ingredient
RU2161894C1 (ru) * 1999-08-10 2001-01-20 НИФ "Ультрасан" Лечебно-профилактическая композиция
GB0010958D0 (en) 2000-05-05 2000-06-28 Novartis Ag Organic compounds
EP1352659A4 (en) * 2000-12-22 2004-06-30 Takeda Chemical Industries Ltd COMBINATION DRUGS
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
WO2003066062A1 (en) 2003-08-14
EP2216025A2 (en) 2010-08-11
NO20043735L (no) 2004-09-07
CA2471964A1 (en) 2003-08-14
JP2005516994A (ja) 2005-06-09
CN1627947A (zh) 2005-06-15
AU2003244446B2 (en) 2006-08-10
AU2003244446A1 (en) 2003-09-02
MXPA04007640A (es) 2004-11-10
KR20040081492A (ko) 2004-09-21
NZ534231A (en) 2007-02-23
HK1077749A1 (zh) 2006-02-24
RU2004127132A (ru) 2005-06-10
US20050203164A1 (en) 2005-09-15
BR0307479A (pt) 2004-12-07
TW200302818A (en) 2003-08-16
EP1476167A1 (en) 2004-11-17
US20070293473A1 (en) 2007-12-20
EP2216025A3 (en) 2010-11-10
RU2353356C2 (ru) 2009-04-27
IL162816A (en) 2010-11-30
GB0203061D0 (en) 2002-03-27
ZA200404960B (en) 2006-05-31
KR20100100994A (ko) 2010-09-15
JP2010241835A (ja) 2010-10-28
PL370255A1 (en) 2005-05-16
CN1301714C (zh) 2007-02-28
TWI330177B (en) 2010-09-11

Similar Documents

Publication Publication Date Title
AP2004003110A0 (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
AP1850A (en) Spiroindolineplperidine derivatives
IL189657A0 (en) N-phenyl-2-pyrimidine-amine derivatives
IL190341A0 (en) Heterocyclocarboxamide derivatives
IL166121A0 (en) Indole-3-sulphur derivatives
EP1522540A4 (en) AZAARENE DERIVATIVES
PL376475A1 (en) N-substituted-2-oxodihydropyridine derivatives
ZA200410409B (en) Use of thio-oxindole derivatives in treatment of hormonerelated conditions
ZA200500471B (en) N-biarylmethyl aminocycloalkanecarboxamide derivatives
IL163868A0 (en) Hermiasterlin derivatives and uses thereof
AU2003222659A8 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
EP1581496A4 (en) 2-SUBSTITUTED 3-PROPENAMIDE DERIVATIVES AND PROCESS FOR THEIR PREPARATION
GB2403474B (en) Amide derivatives
IL162816A0 (en) Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera
AU2003205963A8 (en) Azaphenylalanine derivatives and their use as antithrombotic agents
AU2003235889A8 (en) Amide derivatives
EP1531854A4 (en) O-DERIVATED NOCATHIACIN DERIVATIVES
GB0307231D0 (en) 7-Nitroindoline derivatives and their uses
GB0221270D0 (en) Moke 2
AU2003243397A8 (en) Homo-camptothecin derivatives
ZA200500735B (en) Novel quinuclidine derivatives and their use
GB0208846D0 (en) The moke
GB0209685D0 (en) Towel
GB0221287D0 (en) The shower back scratcher
EP1604995A4 (en) NEW GUANOSINE DERIVATIVES AND THEIR USE